Skip to main content
Have a personal or library account? Click to login
24-h-Ambulatory Blood Pressure Monitoring in Sub-Saharan Africa: Hypertension Phenotypes and Dipping Patterns in Malawian HIV+ Patients on Antiretroviral Therapy Cover

24-h-Ambulatory Blood Pressure Monitoring in Sub-Saharan Africa: Hypertension Phenotypes and Dipping Patterns in Malawian HIV+ Patients on Antiretroviral Therapy

Open Access
|Oct 2021

References

  1. Shah A, Stelzle D, Lee K, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis. Circulation. 2018; 138(11): 110012. DOI: 10.1161/CIRCULATIONAHA.117.033369
  2. Geldsetzer P, Manne-Goehler J, Bärnighausen T, Davies J. What research is needed to address the co-epidemics of HIV and cardiometabolic disease in sub-Saharan Africa? Lancet Diabetes Endocrinol. 2018; 6(1): 79. DOI: 10.1016/S2213-8587(17)30091-8
  3. Feinstein M, Hsue P, Benjamin L, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: A scientific statement from the American Heart Association. Circulation. 2019; 140(2): e98124. DOI: 10.1161/CIR.0000000000000695
  4. Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, et al. The burden of hypertension in sub-Saharan Africa: A four-country cross sectional study. BMC Public Health. 2015; 15: 1211. DOI: 10.1186/s12889-015-2546-z
  5. Todowede O, Mianda S, Sartorius B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa—A systematic review and meta-analysis. Syst Rev. 2009; 8(4): 117. DOI: 10.1186/s13643-018-0927-y
  6. Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular diseases in sub-saharan Africa compared to high-income countries: An epidemiological perspective. Glob Hear. 2020 Feb; 15(1): 15. DOI: 10.5334/gh.403
  7. Nduka C, Stranges S, Sarki A, Kimani P, Uthman O. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: A systematic review with meta-analysis. J Hum Hypertens. 2016; 30(6): 35562. DOI: 10.1038/jhh.2015.97
  8. Fahme S, Bloomfield G, Peck R. Hypertension in HIV-infected adults novel pathophysiologic mechanisms. Hypertension. 2018; 72(1): 4455. DOI: 10.1161/HYPERTENSIONAHA.118.10893
  9. Freiberg M, So-Armah K. HIV and cardiovascular disease: We need a mechanism, and we need a plan. J Am Hear Assoc. 2016; 4(3): 13. DOI: 10.1161/JAHA.116.003411
  10. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hyper. 2018; 36(10): 19532041. DOI: 10.1097/HJH.0000000000001940
  11. Whelton P, Carey R, Aronow W, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association. Hypertension. 2018; 71(6): 1269324. DOI: 10.1161/HYP.0000000000000066
  12. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 2005; 46(1): 15661. DOI: 10.1161/01.HYP.0000170138.56903.7a
  13. Yang W, Melgarejo J, Thijs L, et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019; 322(5): 40920. DOI: 10.1001/jama.2019.9811
  14. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-Up results from the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study. Circulation. 2005; 111(14): 177783. DOI: 10.1161/01.CIR.0000160923.04524.5B
  15. Parati G, Stergiou G, O’Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014; 32(7): 135966. DOI: 10.1097/HJH.0000000000000221
  16. Hsue P, Waters D. Time to recognize HIV infection as a major cardiovascular risk factor. Circulation. 2018; 138(11): 11135. DOI: 10.1161/CIRCULATIONAHA.118.036211
  17. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001; 104(12): 138592. DOI: 10.1161/hc3701.096100
  18. Head G, Shaw J, Dunstan D, et al. Hypertension, white-coat hypertension and masked hypertension in Australia: Findings from the Australian Diabetes, Obesity, and Lifestyle Study 3. J Hypertens. 2019; 37(8): 161523. DOI: 10.1097/HJH.0000000000002087
  19. Amberbir A, Lin SH, Berman J, et al. Systematic review of hypertension and diabetes burden, risk factors, and interventions for prevention and control in malawi: The NCD BRITE consortium. Glob Hear. June 2019; 14(2): 10918. DOI: 10.1016/j.gheart.2019.05.001
  20. van Oosterhout JJ, Hosseinipour M, Muula AS, et al. The Malawi NCD BRITE consortium: Building research capacity, implementation, and translation expertise for noncommunicable diseases. Glob Hear. June 2019; 14(2): 14954. DOI: 10.1016/j.gheart.2019.05.004
  21. Sarafidis P, Lazaridis A, Imprialos K, et al. A comparison study of brachial blood pressure recorded with Spacelabs 90217A and Mobil-O-Graph NG Devices under static and ambulatory conditions. J Hum Hypertens. 2016; 30(12): 7429. DOI: 10.1038/jhh.2016.11
  22. Kasper P, Phiri S, Chaweza T, et al. Ambulatory blood pressure monitoring in PLHIV in Malawi: Preliminary findings. J Acquir Immune Defic Syndr. 2020; 2: 111, Epub ahead of print. DOI: 10.1097/QAI.0000000000002336
  23. Kim Y-S, Davis SCAT, Stok WJ, van Ittersum FJ, van Lieshout JJ. Impaired nocturnal blood pressure dipping in patients with type 2 diabetes mellitus. Hypertens Res. January 2019; 42(1): 5966. DOI: 10.1038/s41440-018-0130-5
  24. Salles G, Reboldi G, Fagard R, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The Ambulatory Blood pressure Collaboration in patients with Hypertension (ABC-H) meta-analysis. Hypertension. 2016; 67(4): 693700. DOI: 10.1161/HYPERTENSIONAHA.115.06981
  25. Verdecchia P, Angeli F, Mazzotta G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: Prognostic implications. Hypertension. July 2012; 60(1): 3442. DOI: 10.1161/HYPERTENSIONAHA.112.191858
  26. Levey A, Stevens L, Schmid C, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9): 60412. DOI: 10.7326/0003-4819-150-9-200905050-00006
  27. Franklin S, O’Brien E, Staessen J. Masked hypertension: Understanding its complexity. Eur Hear J. 2017; 38(15): 11128. DOI: 10.1093/eurheartj/ehw502
  28. Sekoba N, Kruger R, Labuschagne P, Schutte A. Left ventricular mass independently associates with masked hypertension in young healthy adults: The African-PREDICT study. J Hypertens. 2018; 36(8): 168996. DOI: 10.1097/HJH.0000000000001740
  29. Zhang D, Guo Q, An D, Li Y, Wang J. A Comparative Meta-Analysis of Prospective Observational Studies on Masked Hypertension and Masked Uncontrolled Hypertension Defined by Ambulatory and Home Blood Pressure. J Hypertens. 2019; 37(9): 177585. DOI: 10.1097/HJH.0000000000002109
  30. Kent S, Schwartz J, Shimbo D, et al. Race and sex differences in ambulatory blood pressure measures among HIV+ adults. J Am Soc Hypertens. 2017; 11(7): 4207. DOI: 10.1016/j.jash.2017.05.002
  31. Zanuzzi M, Perez Maure M, Lopez S, Cattaneo M, Ricardo C. ISH NIA PS 03–05 Masked hypertension in patients infected with human inmunodeficiency virus (HIV). J Hypertens. 2016; 34(e-Supplement 1): e282. DOI: 10.1097/01.hjh.0000500661.38394.4f
  32. Noubiap J, Nansseu J, Nkeck J, Nyaga U, Bigna J. Prevalence of white coat and masked hypertension in Africa: A systematic review and meta-analysis. J Clin Hypertens. 2018; 20(8): 116572. DOI: 10.1111/jch.13321
  33. Mwasongwe S, Min Y, Booth J, et al. Masked hypertension and kidney function decline: The Jackson Heart Study. J Hypertens. 2018; 36(7): 15241532. DOI: 10.1097/HJH.0000000000001727
  34. Drawz P, Alper A, Anderson A, et al. Masked hypertension and elevated nighttime blood pressure in CKD: Prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016; 11(4): 64252. DOI: 10.2215/CJN.08530815
  35. Landsbergis P, Dobson M, Koutsouras G, Schnall P. Job strain and ambulatory blood pressure: A meta-analysis and systematic review. Am J Public Heal. 2013; 103(3): e61e71. DOI: 10.2105/AJPH.2012.301153
  36. Ware L, Rennie K, Gafane L, et al. Masked hypertension in low-income South African adults. J Clin Hypertens. 2016; 18(5): 396404. DOI: 10.1111/jch.12768
  37. Brandt R. The mental health of people living with HIV/AIDS in Africa: A systematic review. Afr J AIDS Res. 2009; 8(2): 12333. DOI: 10.2989/AJAR.2009.8.2.1.853
  38. Booth J, Diaz K, Seals S, et al. Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: The Jackson Heart study. Hypertension. 2016; 68(2): 50110. DOI: 10.1161/HYPERTENSIONAHA.116.07553
  39. Odili A, Thijs L, Hara A, et al. Prevalence and determinants of masked hypertension among black nigerians compared with a reference population. Hypertension. 2016; 67(6): 124955. DOI: 10.1161/HYPERTENSIONAHA.116.07242
  40. Hänninen M, Niiranen T, Puukka P, Mattila A, Jula A. Determinants of masked hypertension in the general population: The Finn-Home study. J Hypertens. 2011; 29(10): 18808. DOI: 10.1097/HJH.0b013e32834a98ba
  41. Bernardino J, Mora M, Zamora F, et al. Hypertension and isolated office hypertension in HIV-infected patients determined by ambulatory blood pressure monitoring: Prevalence and risk factors. J Acquir Immune Defic Syndr. 2011; 58(1): 549. DOI: 10.1097/QAI.0b013e3182267406
  42. Manner I, Baekken M, Oektedalen O, Sandvik L, Os I. Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure. Blood Press. 2010; 19(3): 18895. DOI: 10.3109/08037051.2010.483055
  43. Franklin S, Thijs L, Hansen T, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: A meta-analysis using the international database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes population. Hypertension. 2012; 59(3): 56471. DOI: 10.1161/HYPERTENSIONAHA.111.180653
  44. Huang Y, Huang W, Mai W, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017; 35(4): 67788. DOI: 10.1097/HJH.0000000000001226
  45. Omboni S, Aristizabal D, De la Sierra A, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14,143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016; 34(11): 218798. DOI: 10.1097/HJH.0000000000001074
  46. de la Sierra A, Vinyoles E, Banegas J, et al. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients. J Hypertens. 2017; 35(12): 238894. DOI: 10.1097/HJH.0000000000001493
  47. Kent S, Bromfield S, Burkholder G, et al. Ambulatory blood pressure monitoring in individuals with HIV: A systematic review and meta-analysis. PLoS One. 2016; 11(2): 117. DOI: 10.1371/journal.pone.0148920
  48. Borkum M, Heckmann J, Manning K, et al. High prevalence of ‘non-dipping’ blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals. PLoS One. 2017; 12(9): 112. DOI: 10.1371/journal.pone.0185003
  49. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui J, Kengne A. Burden of undiagnosed hypertension in sub-saharan Africa: A systematic review and meta-analysis. Hypertension. 2015; 65(2): 2918. DOI: 10.1161/HYPERTENSIONAHA.114.04394
  50. Patel P, Speight C, Maida A, et al. Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi. PLoS Med. 2018; 15(3): e1002523. DOI: 10.1371/journal.pmed.1002523
  51. Kwarisiima D, Atukunda M, Owaraganise A, et al. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health. 2019; 19(1): 210. DOI: 10.1186/s12889-019-6838-6
  52. Seedat Y. Why is control of hypertension in sub-Saharan Africa poor? Cardiovasc J Afr. 2015; 26(4): 1935. DOI: 10.5830/CVJA-2015-065
  53. Macquart de Terline D, Diop B, Bernard M, et al. Substandard Drugs Among Five Common Antihypertensive Generic Medications: An Analysis From 10 African Countries. J Hypertens. 2018; 36(2): 395401. DOI: 10.1097/HJH.0000000000001560
  54. Sando D, Kintu A, Okello S, et al. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. J Int AIDS Soc. 2020; Suppl1(Suppl1): e25507. DOI: 10.1002/jia2.25507
  55. Gonçalves V, Andrade K, Carvalho K, Silva M, Pereira M, Galvao T. Accuracy of Self-Reported Hypertension: A Systematic Review and Meta-Analysis. J Hypertens. 2018; 36(5): 9708. DOI: 10.1097/HJH.0000000000001648
  56. Mancia G, Facchetti R, Cuspidi C, Bombelli M, Corrao G, Grassi G. Limited Reproducibility of MUCH and WUCH: Evidence From the ELSA Study. Eur Hear J. 2020; 41(16): 156571. DOI: 10.1093/eurheartj/ehz651
DOI: https://doi.org/10.5334/gh.945 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 30, 2020
Accepted on: Sep 22, 2021
Published on: Oct 13, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Philipp Kasper, Angellina Nhlema, Andrew de Forest, Hannock Tweya, Thom Chaweza, Beatrice Matanje Mwagomba, Adam M. Mula, Jane Chiwoko, Florian Neuhann, Sam Phiri, Hans-Michael Steffen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.